Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-α
Liku B. Tezera, Magdalena K. Bielecka, Paul Ogongo, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Immune-checkpoint inhibitors: long-term implications of toxicity
Douglas B. Johnson, Caroline A. Nebhan, Javid J. Moslehi, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 4, pp. 254-267
Open Access | Times Cited: 652
The immunoregulatory landscape of human tuberculosis granulomas
Erin McCaffrey, Michele Donato, Leeat Keren, et al.
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 318-329
Open Access | Times Cited: 187
Host-directed immunotherapy of viral and bacterial infections: past, present and future
Robert S. Wallis, Anne O’Garra, Alan Sher, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 2, pp. 121-133
Open Access | Times Cited: 155
PD-1 blockade exacerbates Mycobacterium tuberculosis infection in rhesus macaques
Keith D. Kauffman, Shunsuke Sakai, Nickiana E. Lora, et al.
Science Immunology (2021) Vol. 6, Iss. 55
Open Access | Times Cited: 104
Host‐directed therapy to combat mycobacterial infections*
Gül Kilinç, Anno Saris, Tom H. M. Ottenhoff, et al.
Immunological Reviews (2021) Vol. 301, Iss. 1, pp. 62-83
Open Access | Times Cited: 100
Predicting and Preventing Immune Checkpoint Inhibitor Toxicity: Targeting Cytokines
Jee Hye Kang, Jeffrey A. Bluestone, Arabella Young
Trends in Immunology (2021) Vol. 42, Iss. 4, pp. 293-311
Closed Access | Times Cited: 86
Tissue-resident-like CD4+ T cells secreting IL-17 control Mycobacterium tuberculosis in the human lung
Paul Ogongo, Liku B. Tezera, Amanda Ardain, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 10
Open Access | Times Cited: 82
Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy
Tommaso Morelli, Kohei Fujita, Gil Redelman‐Sidi, et al.
Thorax (2021) Vol. 77, Iss. 3, pp. 304-311
Open Access | Times Cited: 80
Towards efficient immunotherapy for bacterial infection
Timothy R. McCulloch, Timothy J. Wells, Fernando Souza‐Fonseca‐Guimaraes
Trends in Microbiology (2021) Vol. 30, Iss. 2, pp. 158-169
Open Access | Times Cited: 79
The Tuberculous Granuloma and Preexisting Immunity
Sara Cohen, Benjamin H. Gern, Kevin B. Urdahl
Annual Review of Immunology (2022) Vol. 40, Iss. 1, pp. 589-614
Open Access | Times Cited: 61
Genetic and hormonal mechanisms underlying sex-specific immune responses in tuberculosis
Manish Gupta, Geetha Srikrishna, Sabra L. Klein, et al.
Trends in Immunology (2022) Vol. 43, Iss. 8, pp. 640-656
Open Access | Times Cited: 39
Immunotherapies against human bacterial and fungal infectious diseases: A review
Hafsa Qadri, Abdul Haseeb Shah, Mustfa Alkhanani, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 24
TNF in Human Tuberculosis: A Double-Edged Sword
Jae‐Min Yuk, Jin Kyung Kim, In Soo Kim, et al.
Immune Network (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 12
B cell heterogeneity in human tuberculosis highlights compartment-specific phenotype and functional roles
Robert Krause, Paul Ogongo, Liku B. Tezera, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 8
The Pathogenesis of Tuberculosis–The Koch Phenomenon Reinstated
Robert L. Hunter
Pathogens (2020) Vol. 9, Iss. 10, pp. 813-813
Open Access | Times Cited: 59
Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors
Kartik Anand, Geetanjali Sahu, Ethan Burns, et al.
ESMO Open (2020) Vol. 5, Iss. 4, pp. e000866-e000866
Open Access | Times Cited: 53
The licorice flavonoid isoliquiritigenin attenuates Mycobacterium tuberculosis-induced inflammation through Notch1/NF-κB and MAPK signaling pathways
Jinxia Sun, Qingwen Zhang, Gui‐Zhen Yang, et al.
Journal of Ethnopharmacology (2022) Vol. 294, pp. 115368-115368
Closed Access | Times Cited: 36
The paradox of immune checkpoint inhibition re-activating tuberculosis
Mohamed I. M. Ahmed, Liku B. Tezera, Paul Elkington, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 5, pp. 2102512-2102512
Open Access | Times Cited: 30
Recent advances in immunotherapies against infectious diseases
Dharanidharan Ramamurthy, Trishana Nundalall, Sanele Cingo, et al.
Immunotherapy Advances (2020) Vol. 1, Iss. 1
Open Access | Times Cited: 49
Cytocidal macrophages in symbiosis with CD4 and CD8 T cells cause acute diabetes following checkpoint blockade of PD-1 in NOD mice
Hao Hu, Pavel Zakharov, Orion J. Peterson, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 49, pp. 31319-31330
Open Access | Times Cited: 44
Pathogenesis of Human Immunodeficiency Virus-Mycobacterium tuberculosis Co-Infection
Kevin Wong, James Nguyen, Lillie Blair, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 11, pp. 3575-3575
Open Access | Times Cited: 40
Pathological and protective roles of dendritic cells in Mycobacterium tuberculosis infection: Interaction between host immune responses and pathogen evasion
Hongmin Kim, Sung Jae Shin
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 25
No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis
Diana H. Quan, Alexander J. Kwong, Philip M. Hansbro, et al.
European Respiratory Review (2022) Vol. 31, Iss. 164, pp. 210252-210252
Open Access | Times Cited: 24
Increased Tuberculosis Incidence Due to Immunotherapy Based on PD-1 and PD-L1 Blockade: A Systematic Review and Meta-Analysis
Kewei Liu, Dongpo Wang, Cong Yao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy
Hsing-Wu Chen, Yao-Wen Kuo, Chung‐Yu Chen, et al.
The Oncologist (2024) Vol. 29, Iss. 4, pp. e498-e506
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top